Saleh K - Search Results

1

Chemotherapy-free regimen: a new hope in Philadelphia-positive acute lymphoblastic leukemia.

Saleh K, Chahine C, Khalife N. Saleh K, et al. Future Oncol. 2021 Apr;17(11):1265-1267. doi: 10.2217/fon-2020-1220. Epub 2021 Feb 12. Future Oncol. 2021. PMID: 33573414 No abstract available.

2

Characteristics of incident female breast cancer in Lebanon, 1990-2013: Descriptive study of 612 cases from a hospital tumor registry.

Chahine G, El Rassy E, Khazzaka A, Saleh K, Rassy N, Khalife N, Atallah D. Chahine G, et al. Among authors: saleh k. Cancer Epidemiol. 2015 Jun;39(3):303-6. doi: 10.1016/j.canep.2015.03.008. Epub 2015 Mar 29. Cancer Epidemiol. 2015. PMID: 25828075

3

Late Recurrence of Low-Risk Stage II Colorectal Cancer Shortly After Etanercept.

Ibrahim T, Saleh K, Track-Smayra V, Ziade N, Sarraf D, Yazbeck C, Khalife N, Nasr F. Ibrahim T, et al. Among authors: saleh k. J Gastrointest Cancer. 2016 Dec;47(4):506-508. doi: 10.1007/s12029-015-9788-y. J Gastrointest Cancer. 2016. PMID: 26691174 No abstract available.

4

Febuxostat-associated eosinophilic polymyositis in marginal zone lymphoma.

Chahine G, Saleh K, Ghorra C, Khoury N, Khalife N, Fayad F. Chahine G, et al. Among authors: saleh k. Joint Bone Spine. 2017 Mar;84(2):221-223. doi: 10.1016/j.jbspin.2016.10.008. Epub 2016 Dec 7. Joint Bone Spine. 2017. PMID: 27955822

5

Repeated courses of low-dose 2 × 2 Gy radiation therapy in patients with indolent B-cell non-Hodgkin lymphomas.

Saleh K, Michot JM, Schernberg A, Lazarovici J, Chahine C, Danu A, Khalife-Saleh N, Rossignol J, Ghez D, Martin V, Mazeron R, Fermé C, Boros A, Ribrag V, Girinsky T. Saleh K, et al. Cancer Med. 2020 Jun;9(11):3725-3732. doi: 10.1002/cam4.2796. Epub 2020 Apr 6. Cancer Med. 2020. PMID: 32249547 Free PMC article.

6

Acute myeloid leukemia transformed to a targetable disease.

Saleh K, Khalifeh-Saleh N, Kourie HR. Saleh K, et al. Future Oncol. 2020 May;16(14):961-972. doi: 10.2217/fon-2019-0670. Epub 2020 Apr 16. Future Oncol. 2020. PMID: 32297538 Review.

7

RET fusions in non-small-cell lung cancer: an emerging target reshaping the treatment paradigm.

Saleh K, Khalife N, Felefly T. Saleh K, et al. Future Oncol. 2021 Apr;17(12):1445-1448. doi: 10.2217/fon-2020-1297. Epub 2021 Feb 12. Future Oncol. 2021. PMID: 33573417 No abstract available.

8

Rearranged-in-transfection inhibitors: emerging agnostic targeted therapies for solid tumors.

Saleh K, Felefly T, Khalife N, Kourie HR. Saleh K, et al. Pharmacogenomics. 2021 Apr;22(5):247-250. doi: 10.2217/pgs-2021-0002. Epub 2021 Mar 23. Pharmacogenomics. 2021. PMID: 33754802 No abstract available.

9

Cemiplimab: a new option for the treatment of non-small-cell lung cancer.

Khalife N, Kordahi M, Felefly T, Saleh K. Khalife N, et al. Among authors: saleh k. Future Oncol. 2021 Jul;17(20):2559-2562. doi: 10.2217/fon-2021-0343. Epub 2021 May 28. Future Oncol. 2021. PMID: 34047193 No abstract available.

10

KRAS-targeted therapies in advanced solid cancers: drug the undruggable?

Saleh K, Kordahi M, Felefly T, Kourie HR, Khalife N. Saleh K, et al. Pharmacogenomics. 2021 Jul;22(10):587-590. doi: 10.2217/pgs-2021-0045. Epub 2021 Jun 21. Pharmacogenomics. 2021. PMID: 34148378 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

585 results

Search Page

Filters